期刊文献+

缩宫素联合人工破膜对产程及分娩结局的影响 被引量:11

原文传递
导出
摘要 目的:探讨缩宫素联合人工破膜对产程及分娩结局的影响。方法:将宫颈成熟度低的128例孕产妇随机分为对照组与观察组,对照组产妇单纯使用缩宫素促宫颈成熟治疗,观察组产妇人工破膜后1 h应用缩宫素静点,比较两组产程、剖宫产率、产后出血量、胎儿窘迫及新生儿窒息发生率,应用χ2检验及t检验进行统计分析。结果:观察组第一产程及总产程显著少于对照组(P<0.05);观察组与对照组剖宫产率分别为10.6%和29.0%,观察组剖宫产率明显低于对照组(P<0.05);两组产后出血量、胎儿窘迫、新生儿窒息率比较均无统计学差异(P>0.05)。结论:缩宫素联合人工破膜可显著缩短产程,降低剖宫产率。
作者 付长华
出处 《中国妇幼保健》 CAS 北大核心 2013年第31期5247-5248,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献6

二级参考文献24

  • 1巫可珍.口服米索前列醇引产与催产素引产方法的临床观察[J].临床和实验医学杂志,2006,5(10):1588-1588. 被引量:16
  • 2陈乔珠,何静妍,谢静颖.300例社会因素剖宫产术分析[J].中国妇幼保健,2007,22(4):411-413. 被引量:24
  • 3Wielgo SM,Szymu Sik I,Kosinska-Kacyynska K,et al.The influence of dinoprostone on uterine cervix ripening and the course of labour[J].Neuro Endocrinol Lett,2007,28(5):513-517.
  • 4Wemer R.A Clinical evaluation of contro lled-release dinoprostone for cervical ripening-a review of current evidence in ho sp ital and outpatient-settings[J].PerinalMed,2005,33 (4):491 -499.
  • 5Witter FR.Prostaglandin E2 Preparation for Preinduction Cervical Ripeningl Ciinical Obstetrics and Gynecology[J].2000,43 (3):469.
  • 6Mukhopadhyay M,Lim K J,Fairlie FM.Is Propess a better method of induction of labour in nulliparous women[J].J Obstet Gynecol,2002,22(3):294.
  • 7Merborh MK, Bamson S. Managing pain: The fifth vital sign. Nurs Clin Noah Am,2000,35:375-383.
  • 8Buyse I, StzckmanW, ColumbM, et al. Effectof sufentanil on minimum lo- cal analgesic concentrations of epidural bupivacaine, ropivacaine and levobupivacaine in nullipara in early labour. International Journal of Obstetric Anesthesia ,2007,16:22-28.
  • 9Marc VV, Rebekka D, Jasperina D. Determination of the full dose response relation of intrathecal bupivacaine, levobupivacaine, and ropiva- caine, combined with sufentani, for labor analgesia. Anesthesiology,2007, 106 : 149-156.
  • 10Mundle WR, Young DC et al. Vaginal misoprostol for induction of labor: a randomized controlled trial [J]. Obstet Gynecol, 1996, 88 (4 Pt 1): 521.

共引文献40

同被引文献122

  • 1冯雪娜.欣母沛联合宫腔填纱治疗前置胎盘剖宫产产后出血的疗效[J].中国生化药物杂志,2014,34(3):147-148. 被引量:99
  • 2Balki M, Tsen L. Oxytocin protocols for cesarean delivery [J]. lnt Anesthesiol Clin, 2014,52 (2) : 48.
  • 3Leduc D, Biringer A, Lee L, et al. Induction of labour [J]. J Obstet Gynaecol Can, 2013,35(9) :840.
  • 4Simpson KR. Clinicians, guide to the use of oxytocin for labor induction and Augmentation[J]. J Midwifery Wom- ens Health, 2011,56(3) :214.
  • 5Hawkins JS, Wing DA. Current pharmacotherapy options for labor induction[J]. Expert Opin Pharmacother, 2012, 13(14):2 005.
  • 6Zhang J, Branch DW, Ramirez MM, et al. Oxytocin regi- men for labor augmentation, labor progression, and peri- natal outcomes[J]. Obstet Gynecol, 2011, 118 (2 Pt 1) : 249.
  • 7Wei SQ, Luo ZC, Qi HP, et al. High-dose vs low-dose oxytocin for labor augmentation: a systematic review[J]. Am J Obstet Gynecol, 2010,203(4) : 296.
  • 8Montufar-Rueda C, Rodriguez L, Jarquin JD, et al. Se- vere postpartum hemorrhage from uterine atony: a multi- centric study[J]. JPregnancy, 2013 : 525914.
  • 9Gizzo S, Patrelli TS, Gangi SD, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and con- traindications: a systematic review[J]. Reprod Sci, 2013, 20(9):1 011.
  • 10Tunalp O, Souza JP, Gilmezoglu M. New WHO recom- mendations on prevention and treatment of postpartum hemorrhage[J], lnt d Gynaecol Obstet, 2013,123(3) : 254.

引证文献11

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部